Thursday, October 30, 2003 | |
7:00am-8:00am | Continental Breakfast |
8:00am-8:30am | Introductory Remarks Sudhir Srivastava, PhD, MPH National Cancer Institute Bethesda, MD Richard Pazdur, MD Food & Drug Administration Rockville, MD Michael Lotze, MD University of Pittsburgh Pittsburgh, PA |
8:30am-9:00am | Immunohistochemistry of Tumors for Immune Cells George Coukos, MD, PhD University of Pennsylvania Medical Center Philadelphia, PA |
9:00am-9:30am | High Content Cellular Screening Michael Lotze, MD University of Pittsburgh School of Medicine Pittsburgh, PA |
9:30am-10:00am | Serum and Plasma Proteomics Emanuel Petricoin, MD Food and Drug Administration Bethesda, MD |
10:00am-10:15am | Refreshment Break |
10:15am-10:45am | Detection of Circulating Tumor Cells Using Reverse Transcription - PCR Tony Godfrey, PhD University of Pittsburgh Cancer Insitute Pittsburgh, PA |
10:45am-11:15am | Tumor Capture in the Peripheral Blood Hans Loibner, PhD Igeneon AG Viennna, Austria |
11:15am-11:45am | Genomic Analysis of Cancer David Botstein, PhD Princeton University Princeton, NJ |
11:45am-12:15pm | Immunologic Polymorphisms Grant Gallagher, PhD University of Medicine and Dentistry of New Jersey Newark, NJ |
Breakout sessions are by invitation only. Registered Participants will participate in an oral abstract session. | |
12:15pm-1:00pm | Lunch for Registered Participants |
1:00pm-2:15pm | Oral Abstract Session (Registered Participants) |
1:00pm-1:15pm | Lunch for Registered Participants |
1:00pm-2:15pm | High Carbonic Anyhdrase IX Expression Predicts for Renal Cancer Response to IL-2 Therapy Michael B. Atkins, MD Beth Israel Deaconess Medical Center Boston, MA |
1:15pm-1:30pm | The Application of Surface-Enhanced Laser Desorption/Ionization in Discovery, Identification, and Characterization of Serum Biomarkers in Oncology Gerald T. Hoehn, PhD Ciphergen Biosystems, Inc. Freemont, CA |
1:30pm-1:45pm | Precision of the ELISpot Assay Janet L. Lathey, PhD BBI Biotech Gaithersburg, MD |
1:45pm-2:00pm | Multiplexed Direct-Labeled Immunoassays Enable Measurements of a Panel of Prognostic Cancer Biomarkers Robert Negm, PhD Schleicher and Schuell BioScience Keene, NH |
2:00pm-2:15pm | Preoperative MBL Pathway and Prognosis in Colorectal Cancer Henriette Ytting, MD Hvidovre University Hospital Hvidovre, Denmark |
12:15pm-2:15pm | Breakout Sessions (Invited Participants only) |
Immunohistochemistry, Tissue Array Chairs: Guido Sauter, MD University of Basel Basel, Switzerland Peter Bugelski, PhD Centocor Malvern, PA |
|
Genomic Analysis of Cancer Chairs: Ena Wang, MD National Institutes of Health Bethesda, MD John Weinstein, MD, PhD National Cancer Insitute Bethesda, MD |
|
Serum and Plasma/Tumor Proteomics, Protein-Protein Interactions Chairs: Christine Burns, PhD Pierce Boston Technology Center Woburn, MA Monica Panelli, PhD National Institutes of Health Bethesda, MD |
|
Blood Reverse Transcription-PCR; Tumor Capture in Blood Chairs: Steven Shivers, PhD Lakeland Regional Cancer Center Lakeland, FL Michael Perricone, PhD Genzyme Corporation Framingham, MA |
|
High content Cellular Screening of Blood Chairs: Carmen Scheibenbogen, MD Universitats Klinikum Benjamin Franklin D. Lansing Taylor, PhD Cellomics, Inc. Pittsburgh, PA Theresa Whiteside, PhD University of Pittsburgh Cancer Institute Pittsburgh, PA |
|
Immune Polymorphisms Chairs: Natin Damle, PhD Wyeth Research Pearl River, NY Martin Howell, PhD Southampton General Hospital Southampton, United Kingdom |
|
2:15pm-3:00pm | Special Lecture: Biologic Therapy of Melanoma Francesco Marincola, MD National Institutes of Health Bethesda, MD |
3:00pm-3:30pm | Refreshment Break |
3:30pm-3:50pm | Report on Immunohistochemistry, Tissue Array Guido Sauter, MD Peter Bugelski, PhD |
3:50pm-4:10pm | Report on Genomic Analysis of Cancer Ena Wang, MD John Weinstein, MD, PhD |
4:10pm-4:30pm | Report on Serum and Plasma/Tumor Proteomics, Protein-Protein Interactions Christine Burns, PhD Monica Panelli, PhD |
4:30pm-4:50pm | Report on Reverse Transcription - PCR; Tumor Capture in Blood Steven Shivers, PhD Michael Perricone, PhD |
4:50pm-5:10pm | Report on High content Cellular Screening of Blood Carmen Scheibenbogen, MD D. Lansing Taylor, PhD Theresa Whiteside, PhD |
5:10pm-5:30pm | Report on Immune Polymorphisms Natin Damle, PhD Martin Howell, PhD |
5:30pm-6:00pm | Concluding Remarks |